Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/16310
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMuhammad Ahsan-
dc.contributor.authorMuhammad Bilal Azmi-
dc.contributor.authorSyed Danish Haseen Ahmed-
dc.contributor.authorSheikh, Sadia Ikhlaque-
dc.contributor.authorHina Akram Mudassir-
dc.contributor.authorTehseen Iqbal-
dc.contributor.authorFauzia Imtiaz-
dc.date.accessioned2023-01-20T06:56:35Z-
dc.date.available2023-01-20T06:56:35Z-
dc.date.issued2018-03-17-
dc.identifier.citationAhsan, M., Azmi, M. B., Ahmed, S. D. H., Sheikh, S. I., Mudassir, H. A., Iqbal, T., & Imtiaz, F. (2018). Homeostasis model assessment of insulin resistance in non-diabetic heart failure patients: A case-control investigation at tertiary care Hospitals of Karachi. Pakistan journal of pharmaceutical sciences, 31.en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/16310-
dc.description.abstractHeart failure is a progressive, chronic disorder. Insulin resistance (IR) has been more and more involved as a preliminary metabolic perturbance predisposing to hyperglycemia, hyperlipidemia and atherosclerosis with others heart diseases. To investigate the relation of insulin resistance (IR) in non-diabetic heart failure patients this case-control study was carried out to ascertain the presence of IR with the aid of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) in non-diabetic heart failure patients (NDHF patients) compared with healthy controls. The sample size was calculated for both, cases (NDHF patients) and control (healthy subjects), which was initially consisted of 113 respondents each. The study consisted of two phase duration. In Phase I, NDHF patients were approached initially; only 80 patients with NDHF completed the study procedure. In Phase II, 80 healthy subjects were targeted and matched. Fasting blood glucose level (FBGL) and serum insulin was estimated. Mathematical model to quantify β-cell function and insulin resistance was also computed through Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) in both groups. Data was analyzed on SPSS version 16. Mean values with ± standard deviation (SD) of insulin (10.2±4.36) and HOMA-IR (2.52±1.15) were significantly (p<0.05) higher in NDHF patients as compared to control subject (6.4±3.39, 1.45±0.80). Average insulin to glucose ratio was 0.10±0.044 in NDHF patients which was significantly (p<0.0001) lowered in controls i.e., 0.073±0.039. Marginal and matrix plot analysis revealed that a higher patients count have had the HOMA-IR values <1.5 units while opposite scenario was observed in control group. Regression analyses of HOMA-IR with FBGL (as independent indicator) also authenticate the similar pattern. The present study concludes that insulin resistance (decreased insulin sensitivity) is a characteristic finding in Pakistani population of heart failure as compared to matched healthy controls.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences University of KarachiHomeostasis model assessment of insulin resistance in non-diabetic heart failure patients: A case-control investigation at tertiary care Hospitals of Karachien_US
dc.subjectHeart failureen_US
dc.subjectCongestive Heart Failureen_US
dc.subjectInsulin resistanceen_US
dc.subjectHOMA-IRen_US
dc.titleHomeostasis model assessment of insulin resistance in non-diabetic heart failure patients: A case-control investigation at tertiary care Hospitals of Karachien_US
dc.typeArticleen_US
Appears in Collections:Issue No.2 (Supplementary)

Files in This Item:
File Description SizeFormat 
17-SUP-831.htm148 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.